ABVX (ABIVAX) Sof foyda

ABVX (Abivax Pharma) - kompaniyaning tovar belgisi

ABIVAX kompaniyasi yara ochuvchi kolitning noyob terapiyasi bo'lgan obexelimab tufayli narxlarni belgilash imkoniyatiga ega. Kompaniyaning sof foyda dinamikasi -0.47 darajasi joriy qiymatni ifodalaydigan fundamental tendentsiyani aniq namoyish etadi. Klinik sinovlarning so'nggi bosqichlari natijalariga bo'lgan kutishlar asosiy drayver vazifasini o'taydi, R&D xarajatlari esa bozor tomonidan allaqachon hisobga olingan. Brendning innovatsion ishlanmalari og'ir holatdagi bemorlar uchun davolash protokollariga chuqur integratsiya qilingan.

ABVX (Abivax) Sof foyda tarixi 21.02.2024dan 31.10.2026gacha

Abivax Pharma (ABVX) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Abivax SA|ABVX - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi Abivax Corp|ABVX - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati Abivax|ABVX - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi abivax.com|ABVX - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati ABIVAX|ABVX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Abivax Corp|ABVX - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Abivax Corp|ABVX - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Abivax|Shoshilinch likvidlik abivax.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
ABVX - Sof foyda
Kompaniyaning jamlanma tahlili:ABIVAX
ABIVAX asosiy tovari

Surunkali yallig'lanishning uzoq muddatli davolashiga e'tibor qaratadigan ABIVAX (ABVX) biofarmatsevtika biznesi uchun kompaniyaning sof foydasi dori vositalarini ishlab chiqish bosqichlaridagi kapital boshqaruvining samaradorligini aks ettiradi. Ushbu ko'rsatkich daromadlar va xarajatlar o'rtasidagi kunlik farqni aniqlaydi, bu esa investorlarga yashirin operatsion yo'qotishlarni aniqlash va mahsulotlar bozorga chiqishidan oldin aktivlarning haqiqiy barqarorligini baholash imkonini beradi.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda admabiologics.com|Sof daromad PTGX (Protagonist)|IMVT (Immunovant Inc) - Yakuniy foyda|Sof foyda KNSA (Kiniksa Pharmaceuticals Ltd)|Sof moliyaviy natija Grifols Biemat (GRFS)|ADPT - Kompaniyaning sof foydasi|celldex.com (CLDX) - Sof daromad|Aurinia Pharmaceuticals Inc. (AUPH) - Kompaniyaning sof foydasi|Sof daromad BioCryst Pharmaceuticals, Inc.|Sof daromad VERA|Sof foyda Dianthus Corp|Kompaniyaning sof foydasi Pharvaris N.V. (PHVS)|AbCellera Biologics Inc. - Kompaniya foydasi|Sof foyda TRML (Tourmaline Bio)|Precigen Inc (PGEN) - Kompaniyaning sof daromadi|Pharming - Sof foyda|NKTR - Sof foyda|UPB: Sof foyda|ZBIO (zenasbio.com) - Kompaniyaning sof foydasi|IMNM (Immunome) - Sof foyda|Gossamer Bio Inc (GOSS) - Sof moliyaviy natija|Sof daromad KALV (KalVista Pharmaceuticals Inc)|Kompaniyaning sof foydasi SEPN (Septerna Pharma)|Sof foyda PVLA (Pieris Pharmaceuticals)|Sof foyda savarapharma.com SVRA|RIGL: Sof daromad|ANAB (AnaptysBio Inc) - Kompaniya foydasi|ATXS: Sof foyda|enGene Corp (ENGN) - Sof foyda|RAPT (RAPT Therapeutics, Inc.) - Sof foyda|Kompaniyaning sof foydasi JBIO|Sof daromad ACRS (Aclaris Therapeutics, Inc.)|Kompaniyaning sof foydasi KYTX (Kyverna Therapeutics Inc.)|Tiziana Life Sciences PLC - Sof daromad|CABA: Kompaniya foydasi|VTYX - Kompaniyaning sof foydasi|Soliqdan keyingi foyda THTX|AVTX: Sof foyda|Eledon Pharmaceuticals Inc. - Yakuniy foyda|AGEN (Agenus Inc) - Sof foyda|Sof foyda Climb Bio, Inc|Kompaniyaning sof foydasi Zura Bio Limited (ZURA)|ATYR (atyrpharma.com) - Yakuniy foyda|Kompaniyaning sof foydasi Adagene Inc. ADAG|IMA - Sof daromad|Shattuck Therapeutics - Sof foyda|EQ - Sof foyda|CNTB (connectbiopharm.com) - Sof daromad|Immunic - Yakuniy foyda|ATRA (Atara Biotherapeutics, Inc.) - Sof foyda|InflaRx GmbH (IFRX) - Sof moliyaviy natija|Kompaniyaning sof foydasi X4 Pharma (XFOR)|Sof daromad adicetbio.com ACET|Kompaniyaning sof foydasi Celularity CELU|INMB - Sof daromad|BRNS: Sof daromad|KZR - Sof foyda|SAB Biotherapeutics, Inc (SABS) - Kompaniyaning sof foydasi|Kompaniya foydasi AKTX|ENLV (Enlivex Therapeutics Ltd) - Sof foyda|Kompaniyaning sof daromadi Q32 Bio Corp QTTB|Sof foyda GOVX|Sof foyda Edesa Biotech Inc (EDSA)|Sof foyda IBIO (iBio Corp)|Carisma Therapeutics Inc - Kompaniyaning sof foydasi|XTL Biopharmaceuticals - Sof foyda|Sof moliyaviy natija Bolt Biotherapeutics BOLT|HCWB (hcwbiologics.com) - Sof daromad|APVO (Aptevo Therapeutics Inc.) - Kompaniyaning sof foydasi|AIM (AIM ImmunoTech) - Sof foyda|Sof foyda Aditxt Corp|Sof daromad GRI (GRI Bio, Inc.)|xortx.com - Kompaniya foydasi|Sof foyda HIND (Vyome Holdings)|Sof foyda Revelation Biosciences Inc REVB|Indaptus - Sof foyda|SCNI: Kompaniyaning sof foydasi|CALI (calcimedica.com) - Sof daromad|AFMD (Affimed N.V.) - Kompaniyaning sof foydasi|Sof daromad ALLK|Kompaniya foydasi HOOK (HOOKIPA)|Kompaniyaning sof foydasi IGM Biosciences, Inc. (IGMS)|ITOS: Soliqdan keyingi foyda|Sof foyda OCEA (Ocean Biomedical, Inc.)|Yakuniy foyda TCBP|Third Harmonic Bio, Inc. - Sof foyda